Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Jan 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2009 Jul 12;16(1):132–133. doi: 10.1016/j.bbmt.2009.05.017

Table 1.

	+/+ (n=344)	+/- (n=39)	-/- (n=8)
Grades 2-4	309 (90%) OR=1	34 (87%) OR=0.77 (0.28-2.10, p=.61)	6 (75%) OR=0.34 (0.07-1.75, p=.20)
Grades 3-4	124 (36%) OR=1	13 (33%) OR=0.89 (0.44-1.79, p=.74)	1 (13%) OR=0.25 (0.03-2.08, p=.20)
Skin^*	288 (84%) OR=1	18 (46%) OR=0.89 (0.37-2.11, p=.79)	4 (50%) OR=0.19 (0.05-0.80, p=.02)
Liver^*	159 (46%) OR=1	32 (82%) OR=0.65 (0.33-1.30, p=.22)	2 (25%) OR=0.39 (0.08-1.95, p=.25)
Gut^*	219 (64%) OR=1	14 (36%) OR=0.82 (0.42-1.61, p=.57)	5 (63%) OR=0.95 (0.22-4.05, p=.95)
Chronic^**	207 (60%) HR=1	19 (49%) HR=0.96 (0.60-1.53, p=.85)	3 (38%) HR=0.45 (0.14-1.41, p=.17)
Relapse	66 (19%) HR=1	9 (23%) HR=1.71 (0.85-3.43, p=.13)	3 (38%) HR=1.80 (0.57-5.71, p=.32)
Mortality	167 (49%) HR=1	24 (62%) HR=1.59 (1.04-2.44, p=.03)	4 (50%) HR=1.01 (0.37-2.71, p=.99)

^*

organ-specific GVHD of any grade (1-4)

^**

clinical extensive chronic GVHD